Metabolomic evaluation of Mitomycin C and rapamycin in a personalized treatment of pancreatic cancer.

Pharmacol Res Perspect · 2014 · PMC4186447 · PMID 25505613

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

more or less significantno p-value reported

In this case, it is likely that MMC alters the synthesis of acylcarnitines and that different derivatives are more or less significant depending on which treatment it is compared to.

also in 311 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.